Sonova Stock Gains on Morgan Stanley Price Target Increase

Sonova Holding AG's stock has been gaining momentum in recent days, driven by positive sentiment in the Swiss Large & Mid Cap Index and a fresh price-target increase from Morgan Stanley.

The bank raised its target for Sonova to 245 Swiss francs from 205 Swiss francs, representing an increase of roughly 19.5 percent. This signals stronger confidence in the company's earnings potential over the next 12 to 18 months.

Morgan Stanley analysts described hearing aids as their preferred subsector within European medtech, expecting market-value growth to return to about 5 percent over the next 12 to 18 months.

Sonova shares are listed on SIX Swiss Exchange and form part of the SLI, giving the stock high visibility among Swiss institutional investors. The company is also shaping the hearing-aid market with new products in the premium segment, including rechargeable in-the-ear hearing aids.